MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/mus.27233

Медицинская библиотека · Muscle & nerve · 2021

Short-term effect of low-dose rituximab on myasthenia gravis with muscle-specific tyrosine kinase antibody.

Zhou Yufan, Yan Chong, Gu Xinyu, Zhou Lei, Lu Jun, Zhu Wenhua, Huan Xiao, Luo Sushan, Zhong Huahua, Lin Jie, Lu Jiahong, Zhao Chongbo, Xi Jianying

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

INTRODUCTION/AIMS: The study aims to investigate the short-term efficacy of low-dose rituximab and its effect on immunological biomarker levels in myasthenia gravis (MG) patients with antibodies against muscle-specific tyrosine kinase (MuSK-MG).

METHODS

Twelve MuSK-MG patients were enrolled in this prospective, open-label, self-controlled pilot study. Clinical severity was evaluated at baseline and 6 mo after a single rituximab treatment (600 mg). B lymphocyte subtypes, MuSK antibody titers, together with levels of immunoglobulins, serum B-cell activating factor (BAFF), a proliferation-inducing ligand (APRIL), soluble CD40L, and four exosomal microRNAs were evaluated. A correlation matrix to reveal pairwise relationships among above variables was also generated.

RESULTS

The single rituximab treatment significantly lowered the clinical severity scores and reduced daily dosage of prednisone (P = .032) at 6 mo. MuSK antibody titers decreased (P = .035) without significant changes in immunoglobulin levels. Serum BAFF level increased (P = .010), which negatively correlated with the percentages of B cells in lymphocytes as well as clinical severity. Additionally, serum exosomal miR-151a-3p showed a reduction of 28.1% (P = .031).

DISCUSSION: We confirmed the clinical efficacy of low-dose rituximab in MuSK-MG, accompanied by a decrease in MuSK antibody titers and an increase in serum BAFF. Serum BAFF levels negatively correlated with B-cell counts as well as clinical severity.

Для цитирования: Zhou Yufan, Yan Chong, Gu Xinyu, Zhou Lei, Lu Jun, Zhu Wenhua, Huan Xiao, Luo Sushan, Zhong Huahua, Lin Jie, Lu Jiahong, Zhao Chongbo, Xi Jianying. Short-term effect of low-dose rituximab on myasthenia gravis with muscle-specific tyrosine kinase antibody.. Muscle & nerve. 2021. DOI: 10.1002/mus.27233.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.